Allogene Therapeutics, Inc. - ALLO

SEC FilingsOur ALLO Tweets

About Gravity Analytica

Recent News

  • 09.03.2025 - Citi's 2025 Biopharma Back to School Conference
  • 08.29.2025 - Citi’s 2025 Biopharma Back to School Conference
  • 08.27.2025 - Allogene Therapeutics Announces Participation in Upcoming Investor Conference
  • 08.27.2025 - Allogene Therapeutics Announces Participation in Upcoming Investor Conference
  • 08.27.2025 - Allogene Therapeutics Announces Participation in Upcoming Investor Conference
  • 08.13.2025 - The Allogene Therapeutics Second Quarter 2025 Conference Call
  • 08.13.2025 - 10-Q: Quarterly report which provides a continuing view of a company’s financial position
  • 08.13.2025 - 8-K: Report of unscheduled material events or corporate event
  • 08.13.2025 - Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
  • 08.13.2025 - Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update

Recent Filings

  • 08.13.2025 - 8-K Current report
  • 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.13.2025 - EX-99.1 EX-99.1
  • 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.08.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors